Literature DB >> 11587482

Sinusoidal efflux of taurocholate is enhanced in Mrp2-deficient rat liver.

H Akita1, H Suzuki, Y Sugiyama.   

Abstract

PURPOSE: It has been shown that plasma concentration and urinary excretion of bile acids is elevated under the cholestatic/ hyperbilirubinemic conditions. Previously, it was demonstrated that the plasma concentration of bile acids was elevated in the multidrug resistance-associated protein 2 (Mrp2)-deficient rats. The purpose of the present study was to compare the sinusoidal efflux clearance of taurocholate (TC) between Mrp2-deficient Eisai hyperbilirubinemic rats (EHBR) and normal rats.
METHOD: Hepatic disposition of the [3H]TC was examined in the perfused liver. Apparent efflux clearance (PSnet, eff) of [3H]TC from hepatocytes to outflow across the sinusoidal membrane was defined as the amount of [3H]TC excreted into the outflow from the liver divided by hepatic AUC of [3H]TC. Additionally, influx clearance (PSinf) was also determined by multiple indicator dilution method because PSnet, eff is also affected by PSinf.
RESULTS: PSnet, eff was significantly higher in EHBR than that in Sprague-Dawley (SD) rats (16.6 +/- 1.7 vs. 6.1 +/- 1.3 microL/min/g liver, P < 0.01). In contrast, PSinf was comparable between SD rats and EHBR. Kinetic analysis suggested that the intrinsic clearance for the efflux of [3H]TC across the sinusoidal membrane in EHBR was higher than that in SD rats (10.4 +/- 1.0 v.s. 23.3 +/- 1.7 microL/min/g liver, P < 0.01).
CONCLUSIONS: Enhanced sinusoidal efflux of TC in EHBR may be related to the altered disposition of bile acids in the mutant rats. Because Mrp3 transports TC and its expression is induced on the basolateral membrane of Mrp2-deficient rats, the enhanced sinusoidal efflux of TC in EHBR may be accounted for, at least partially, by the increased expression of Mrp3.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11587482     DOI: 10.1023/a:1010918825019

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  30 in total

Review 1.  Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport.

Authors:  R P Oude Elferink; D K Meijer; F Kuipers; P L Jansen; A K Groen; G M Groothuis
Journal:  Biochim Biophys Acta       Date:  1995-07-17

2.  Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump.

Authors:  H Akita; H Suzuki; K Ito; S Kinoshita; N Sato; H Takikawa; Y Sugiyama
Journal:  Biochim Biophys Acta       Date:  2001-03-09

3.  Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.

Authors:  I Tamai; J Nezu; H Uchino; Y Sai; A Oku; M Shimane; A Tsuji
Journal:  Biochem Biophys Res Commun       Date:  2000-06-24       Impact factor: 3.575

4.  Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane.

Authors:  J König; D Rost; Y Cui; D Keppler
Journal:  Hepatology       Date:  1999-04       Impact factor: 17.425

Review 5.  Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance.

Authors:  J König; A T Nies; Y Cui; I Leier; D Keppler
Journal:  Biochim Biophys Acta       Date:  1999-12-06

6.  Expression cloning of a rat liver Na(+)-independent organic anion transporter.

Authors:  E Jacquemin; B Hagenbuch; B Stieger; A W Wolkoff; P J Meier
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

7.  Characterization of inducible nature of MRP3 in rat liver.

Authors:  K Ogawa; H Suzuki; T Hirohashi; T Ishikawa; P J Meier; K Hirose; T Akizawa; M Yoshioka; Y Sugiyama
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-03       Impact factor: 4.052

8.  Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3).

Authors:  T Hirohashi; H Suzuki; Y Sugiyama
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

Review 9.  Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver.

Authors:  P J Meier; U Eckhardt; A Schroeder; B Hagenbuch; B Stieger
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

10.  Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter.

Authors:  B Hagenbuch; P J Meier
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more
  10 in total

Review 1.  Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism.

Authors:  Paul A Dawson; Melissa L Hubbert; Anuradha Rao
Journal:  Biochim Biophys Acta       Date:  2010-06-09

Review 2.  An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

Authors:  Kyunghee Yang; Kathleen Köck; Alexander Sedykh; Alexander Tropsha; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2013-05-07       Impact factor: 3.534

3.  Hepatobiliary transport of YM466, a novel factor Xa inhibitor, in rats.

Authors:  Yuji Mano; Takashi Usui; Hidetaka Kamimura
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

Review 4.  Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport.

Authors:  Kousei Ito; Hiroshi Suzuki; Toshiharu Horie; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

5.  Shiga-like toxin II impairs hepatobiliary transport of doxorubicin in rats by down-regulation of hepatic P glycoprotein and multidrug resistance-associated protein Mrp2.

Authors:  Kazuhiko Hidemura; Ying Lan Zhao; Katsuki Ito; Akimasa Nakao; Yasuaki Tatsumi; Hiroaki Kanazawa; Kenzo Takagi; Michio Ohta; Takaaki Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

Review 6.  Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury.

Authors:  Kyunghee Yang; Cen Guo; Jeffrey L Woodhead; Robert L St Claire; Paul B Watkins; Scott Q Siler; Brett A Howell; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2016-02       Impact factor: 3.534

7.  Species differences in hepatobiliary disposition of taurocholic acid in human and rat sandwich-cultured hepatocytes: implications for drug-induced liver injury.

Authors:  Kyunghee Yang; Nathan D Pfeifer; Kathleen Köck; Kim L R Brouwer
Journal:  J Pharmacol Exp Ther       Date:  2015-02-23       Impact factor: 4.030

Review 8.  Bile acid transporters.

Authors:  Paul A Dawson; Tian Lan; Anuradha Rao
Journal:  J Lipid Res       Date:  2009-06-04       Impact factor: 5.922

9.  Importance of detoxifying enzymes in differentiating fibrotic development between SHRSP5/Dmcr and SHRSP rats.

Authors:  Hisao Naito; Xiaofang Jia; Husna Yetti; Yukie Yanagiba; Hazuki Tamada; Kazuya Kitamori; Yumi Hayashi; Dong Wang; Masashi Kato; Akira Ishii; Tamie Nakajima
Journal:  Environ Health Prev Med       Date:  2016-05-21       Impact factor: 3.674

10.  Hepatic basolateral efflux contributes significantly to rosuvastatin disposition II: characterization of hepatic elimination by basolateral, biliary, and metabolic clearance pathways in rat isolated perfused liver.

Authors:  Nathan D Pfeifer; Arlene S Bridges; Brian C Ferslew; Rhiannon N Hardwick; Kim L R Brouwer
Journal:  J Pharmacol Exp Ther       Date:  2013-09-30       Impact factor: 4.030

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.